Compounds > cipamfylline
Page last updated: 2024-08-25

cipamfylline and rolipram

cipamfylline has been researched along with rolipram in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (80.00)18.2507
2000's0 (0.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abraham, A; Adams, DR; Allcock, RW; Anthony, D; Baillie, GS; Bogum, J; Christian, F; Day, JP; Houslay, DM; Houslay, MD; Huston, E; Jiang, Z; Klussmann, E; Lindsay, B; Martin, EK; Rae, RL; Riddell, T; Rosair, GM; Sookup, S1
Badger, AM; Esser, KM; Olivera, DL1
Arch, JR; Buckle, DR; Connolly, BJ; Fenwick, AE; Foster, KA; Murray, KJ; Readshaw, SA; Smallridge, M; Smith, DG1
Cieslinski, LB; Michell, MP; Ohlstein, EH; Sauermelch, CF; Shiloh, AO; Sulpizio, A; Torphy, TJ; Willette, RN1
Buckingham, JC; Cover, PO; Kumari, M; Poyser, RH1

Other Studies

5 other study(ies) available for cipamfylline and rolipram

ArticleYear
Elucidation of a structural basis for the inhibitor-driven, p62 (SQSTM1)-dependent intracellular redistribution of cAMP phosphodiesterase-4A4 (PDE4A4).
    Journal of medicinal chemistry, 2011, May-12, Volume: 54, Issue:9

    Topics: Adaptor Proteins, Signal Transducing; Animals; Catalytic Domain; CHO Cells; Cricetinae; Cricetulus; Crystallography, X-Ray; Cyclic Nucleotide Phosphodiesterases, Type 4; Isoenzymes; Models, Molecular; Phosphodiesterase 4 Inhibitors; Pyridines; Rolipram; Sequestosome-1 Protein; Spiro Compounds; Stereoisomerism; Structure-Activity Relationship; Xanthines

2011
Beneficial effects of the phosphodiesterase inhibitors BRL 61063, pentoxifylline, and rolipram in a murine model of endotoxin shock.
    Circulatory shock, 1994, Volume: 44, Issue:4

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Cells, Cultured; Cyclic Nucleotide Phosphodiesterases, Type 4; Disease Models, Animal; Macrophages, Peritoneal; Male; Mice; Mice, Inbred C57BL; Pentoxifylline; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Pyrrolidinones; Rolipram; Shock, Septic; Tumor Necrosis Factor-alpha; Xanthines

1994
Inhibition of cyclic nucleotide phosphodiesterase by derivatives of 1,3-bis(cyclopropylmethyl)xanthine.
    Journal of medicinal chemistry, 1994, Feb-18, Volume: 37, Issue:4

    Topics: Adenosine; Alkylation; Animals; Binding Sites; Brain; Male; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Rolipram; Structure-Activity Relationship; Xanthines

1994
Identification, characterization, and functional role of phosphodiesterase type IV in cerebral vessels: effects of selective phosphodiesterase inhibitors.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 1997, Volume: 17, Issue:2

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Basilar Artery; Cerebral Arteries; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Dogs; Drug Evaluation, Preclinical; Ischemic Attack, Transient; Isoenzymes; Male; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Prostaglandin Endoperoxides, Synthetic; Pyrrolidinones; Rolipram; Second Messenger Systems; Subarachnoid Hemorrhage; Thromboxane A2; Vasoconstrictor Agents; Vasodilator Agents; Xanthines

1997
Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by three selective type-4 phosphodiesterase inhibitors: in vitro and in vivo studies.
    British journal of pharmacology, 1997, Volume: 121, Issue:3

    Topics: Adrenocorticotropic Hormone; Animals; Dose-Response Relationship, Drug; Hypothalamo-Hypophyseal System; Male; Phosphodiesterase Inhibitors; Pituitary-Adrenal System; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Rolipram; Xanthines

1997